World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
24337
World Ranking
12368
National Ranking
667

Overview

Peter J. Wild is affiliated with the Frankfurt Institute for Advanced Studies in Germany. Their research primarily revolves around medicine and biochemistry, genetics, and molecular biology, with a significant focus on oncology and cancer-related fields.

The scientist's work covers a broad spectrum of subfields within medical science, including pulmonary and respiratory medicine, surgery, oncology, molecular biology, and cancer research. Their main topics of investigation include prostate cancer treatment and research, cancer genomics and diagnostics, prostate cancer diagnosis and treatment, radiomics and machine learning in medical imaging, bladder and urothelial cancer treatments, cholangiocarcinoma and gallbladder cancer studies, and cancer immunotherapy and biomarkers.

Peter J. Wild has contributed to several frequent publication venues, such as:

  • Die Pathologie
  • Cancers
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Frontiers in Oncology
  • Scientific Reports

Among their recent papers are:

  • Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer, 2021, JAMA Oncology
  • Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis, 2020, Cancer Cell
  • Strategies to enable large-scale proteomics for reproducible research, 2020, Nature Communications
  • The proteogenomic subtypes of acute myeloid leukemia, 2022, Cancer Cell
  • AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer, 2020, The Journal of Experimental Medicine

Frequent co-authors collaborating with Peter J. Wild include:

  • Henning Reis
  • Katrin Bankov
  • Jens Köllermann
  • Felix K.-H. Chun
  • Melanie Demes

Best Publications

  • Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

    Christopher E. Barbieri;Sylvan C. Baca;Sylvan C. Baca;Michael S. Lawrence;Francesca Demichelis;Francesca Demichelis

  • WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.

    Christoph Wissmann;Peter Johannes Wild;Simone Kaiser;Stefan Roepcke

  • Automated Gleason grading of prostate cancer tissue microarrays via deep learning

    Eirini Arvaniti;Eirini Arvaniti;Kim S. Fricker;Michael Moret;Niels Rupp

  • Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells

    Cornel Fraefel;Song Song;Filip Lim;Phung Lang

  • Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation

    Ernst Holler;Gerhard Rogler;Hans H Herfarth;Julia Brenmoehl

  • Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer

    David N. Church;David N. Church;Ellen Stelloo;Remi A. Nout;Nadejda Valtcheva

  • Reliable detection of subclonal single-nucleotide variants in tumour cell populations

    Moritz Gerstung;Christian Beisel;Markus Rechsteiner;Peter Wild

  • Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.

    Xiangpeng Dai;Wenjian Gan;Xiaoning Li;Xiaoning Li;Shangqian Wang

  • Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors : a systematic expression analysis

    Alexander Hamm;Juergen Veeck;Nuran Bektas;Peter J Wild

  • Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma

    Ramin Massoumi;Silke Kuphal;Claus Hellerbrand;Bodo Haas

  • TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer

    Anna C. Groner;Laura Cato;Jonas de Tribolet-Hardy;Tiziano Bernasocchi

  • Serotonin promotes tumor growth in human hepatocellular cancer

    Christopher Soll;Jae Hwi Jang;Marc-Oliver Riener;Wolfgang Moritz

  • Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer

    Jean Philippe P Theurillat;Jean Philippe P Theurillat;Namrata D. Udeshi;Wesley J. Errington;Wesley J. Errington;Tanya Svinkina

  • Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas

    Marc-Oliver Riener;Frank Stenner;Heike Liewen;Christopher Soll

  • Prediction of Progression of Non-Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study

    Maximilian Burger;Madelon N.M. van der Aa;Johanna M.M. van Oers;Anke Brinkmann

  • Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer

    Igor Cima;Ralph Schiess;Peter Wild;Martin Kaelin

  • Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.

    Emmanouil Fokas;Emmanouil Fokas;Anke Schlenska-Lange;Bülent Polat;Gunther Klautke

  • Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors.

    Eva Klopocki;Glen Kristiansen;Peter J. Wild;Irina Klaman

  • Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice

    Joachim Albers;Michal Rajski;Désirée Schönenberger;Sabine Harlander

  • Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases

    B. Becker;G. Multhoff;B. Farkas;P.-J. Wild

Frequent Co-Authors

Arndt Hartmann
Arndt Hartmann University of Erlangen-Nuremberg
Holger Moch
Holger Moch University of Zurich
Glen Kristiansen
Glen Kristiansen University Hospital Bonn
Edgar Dahl
Edgar Dahl RWTH Aachen University
Silke Gillessen
Silke Gillessen Universita della Svizzera Italiana
Anja-Katrin Bosserhoff
Anja-Katrin Bosserhoff University of Erlangen-Nuremberg
Torben F. Ørntoft
Torben F. Ørntoft Aarhus University
Mathias Ackermann
Mathias Ackermann University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career opportunities in medicine often goes beyond the traditional path of becoming a doctor. There are flexible online programs for those interested in healthcare roles that blend patient care, mental health, and management. For example, aspiring nurses can jumpstart their careers through a 9 month lpn program, which allows them to join the workforce quickly and start gaining hands-on experience.

For those passionate about mental health, online pmhnp programs can equip students to become Psychiatric Mental Health Nurse Practitioners and address the growing demand for mental health professionals.

If you are interested in the business and management side of healthcare, consider a bachelors in health administration. This degree prepares students for leadership roles in various healthcare organizations. There are also programs designed for cost-conscious students, such as the cheapest master's in healthcare administration, which can propel you to senior management positions without excessive tuition fees.

These related online degrees and career pathways offer diverse options for making a difference in healthcare, even if you opt for a non-traditional route.

Best Scientists Citing Peter J. Wild

Trending Scientists

Recently Published Articles